CTRI/2017/12/010915尚未招募3 期
Efficacy of Vamana and Virechana Karma along with Pippalikhanda in the management of Amlapitta w.s.r. to Hyperacidity: an open labelled randomized comparative clinical trial
Institute for Post Graduate Training And Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with all forms of Amlapitta who are
- •clinically fit to undergo Virechana and
- •2. Patient presenting with pratyatm lakshan of
- •Amlapitta like Utklesha (Nausea), Hriddaha
- •(Heart Burn), Kanthadaha (Burning sensation
- •in throat), Amlodgara (Acid eruption), Vanti
- •(Vomiting), Udara shoola (Pain in abdomen)
- •with and without other pratyatm lakshan like
- •Aruchi Adhmana etc.
- •3. Patients of either sex between 18-60 year
排除标准
- •1. Patients below 18 year and above 60 years of
- •2. Patients who are clinically unfit for
- •Vamana and Virechana karma.
- •3. Subject suffering from acute
- •gastrointestinal disorders like:
- •a) Peptic ulcer
- •b) Duodenal ulcer
- •c) Pancreatic and hepatic disease
- •d) Motility disorder
- •e) Inflammatory bowel disease
- •4. Lactating and pregnant women
- •5. Any other severe complicating systemic
- •6. Patients who are not willing to be included
- •in the study.
研究者
相似试验
尚未招募
3 期
Comparison of Vamana karma and Virechana karma followed by Navakarshika Guggulu in Sheetapitta-Urticaria.CTRI/2020/10/028237Institute for Post Graduate Teaching and Research in Ayurveda Jamnagar
已完成
3 期
Comparision between Vamana Karma and Virechana Karma in Shwitra or Vitiligo.CTRI/2020/03/023750IPGT and RA22
尚未招募
3 期
Effect of Vamana, Virechana in DadruCTRI/2022/03/041150Institute of Teaching and Research in Ayurveda
尚未招募
3 期
EFFICACY OF VIRECHANA AND UDWARTANA KARMA IN THE MANAGEMENT OF STHAULYA (OBESITY)CTRI/2021/04/032623Government Akhandanand Ayurved Mahavidyalaya
尚未招募
2 期
To check the effectiveness of vamana karma(panchakarma) and maharasnadi kwatha in PCOS conditioCTRI/2021/02/031444Dr Sushmitha S Hadimane
